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GLOSSARY OF TERMS 
 
Hydronephrosis – dilatation of the kidney by urine accumulation 
 
Hydroureter – dilatation of the ureter 
 
Hydroureteronephrosis – combination of hydronephrosis and hydroureter 
 
Obstructive Uropathy – structural or functional interference with normal urine flow 
anywhere along the urinary tract from the renal tubule to the urethra. 
 
Ureterostomy –the creation of a stoma (an artificial outlet) for a ureter 
 
Urinary diversion –one of several surgical procedures to re-route urine flow from its 
normal pathway 
 
Valve ablation – disruption of the obstructing membrane of posterior urethral valve 
usually under direct vision by cystoscope using an endoscopic loop, Bugbee 
electrocauterisation, or laser fulguration. 
 
Vesicostomy – a surgically created connection between the urinary bladder and the skin 
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Posterior urethral valve (PUV) is a congenital obstructing membrane of the male urethra. 
It is the commonest cause of bladder outlet obstruction in male children. PUV as a cause 
of obstructive uropathy is an important cause of end stage renal failure (ESRF) in 
children. Early detection and surgical intervention can slow down progression to ESRF. 
      A retrospective, folder review of children diagnosed with PUV at Red Cross Children 
Hospital (RXCH) from January 2002 to January 2009 was undertaken to: 
• determine patients’ characteristics and method of clinical presentation 
• audit timing of diagnosis, and timing and type of surgical intervention and 
• determine disease progression 
      Forty-eight patients were reviewed with median duration of follow up 52 of months 
(IQR 24 - 107 months).  
 Nineteen (39.6%) out of the 48 study subjects were diagnosed by prenatal ultrasound 
scan. Of the remaining 29 (60.4%) who were diagnosed postnatally, age at diagnosis 
ranged from 1day to 2,950 days (median 17, IQR 1.0 – 90.5 days). On the whole, 17 
(58.6%) of the 29 postnatally diagnosed cases were diagnosed within the first 3 months 
of age.  
Racial distribution were 34 (70.83%) Coloured, 13 (27.01%) Blacks and 1 (2.01%) 
White. None (0.00%) was of Asian origin. 
Commonest clinical presentation were urinary tract infection (10 cases), palpable 
abdominal mass (4 cases), voiding dysfunction (3 cases, 2 as dribbling urine), enuresis (2 
cases). 
Three types of surgery were identified in the management of PUV in this study either 
alone or in combination; valve ablation, vesicostomy, and cutaneous ureterostomies. 
Valve ablation alone was used in 29 (60.4%) patients, vesicostomy alone in 12 (25.0%), 
and the rest 7 (14.5%) combination surgery. 
The median time interval from confirmation of PUV to primary surgical intervention was 











At end of follow up period, estimated glomerular filtration rate  and thus stage of chronic 
kidney disease could be determined for 37 patients of which 20 (54.1%) were in stage 1. 
Only 1 (2.7%) patient had reached ESRF over time duration of 5 years 3 months. He had 
subsequently undergone successful renal transplant with graft function preserved after 4 
years 2 months (serum creatinine at last follow up is 48 µmol/l). No death had been 
recorded over the study period but significant numbers (29%) have been lost to follow up 
for over a year. Prognostic factors identified were serum creatinine at presentation and at 
1 year of age, as well as the nadir serum creatinine in the 1st year after surgical relief of 
the obstruction. 
 Though significant successes were identified in terms of promptness of diagnosis and 
surgical intervention, several areas in follow up care need improvement. 
 PUV could be successfully managed in the African continent to decrease progression to 





























Posterior urethral valve (PUV) is an abnormal congenital obstructing membrane that is 
located within the posterior urethra of males. Figure 1.1,  Appendix 1. 
The condition thus occurs exclusively in males.1 This valve is the most common cause of 
bladder outlet obstruction in male children.2 The valve causes mechanical obstruction to 
normal bladder emptying resulting in increased voiding pressures that may alter normal 
development of the foetal bladder and kidneys.2 PUV represents a spectrum of 
obstructive severity, ranging from disease that may be incompatible with postnatal life 
due to severe pulmonary hypoplasia, to that which is minimal and may not manifest until 
later in life. The degree of obstruction caused by this abnormality depends on the 
configuration of the obstructive membrane within the urethra. Typically, children with 
higher degrees of obstruction present early in life (outside prenatal detection) with severe 
symptoms like renal failure and respiratory distress secondary to pulmonary hypoplasia 
from oligohydramnios whilst those with milder obstruction may present late with mild 
obstructive symptoms limited to voiding dysfunction.2 PUV as a cause of obstructive 
uropathy is an important cause of end stage renal failure (ESRF) in children. Early 
diagnosis and intervention to decrease bladder pressure and stabilise the upper urinary 
tract are important to delay or prevent the progression of renal insufficiency with its 





































1.1 Overview of functions of the kidney and the metabolic effect of 
kidney failure 
The kidney plays important role in the metabolic processes of the body with respect to 
the homeostasis of fluid, electrolytes, and acid-base. It is the principal organ responsible 
for the excretion of the nitrogenous waste products from protein metabolism. Besides 
these homeostatic roles, the kidney plays central role in erythropoiesis by producing the 
hormone erythropoietin which is essential for the proliferation of the erythroid 
precursors. The production of one-alpha (1-α) hydroxylase enzyme by the proximal 
tubular cells of the kidney makes the kidney a key partner in vitamin D metabolism and, 
indeed, in bone and mineral metabolism. 
In the event of kidney failure, these important homeostatic and endocrine functions 
become deranged with drastic, and often fatal, consequences: 
• Fluid overload occurs if intake is not matched with output 
• Electrolyte abnormalities occur with the tendency for life-threatening 
hyperkalaemia 
• There is acid-base derangement with development of metabolic acidosis 
• Retention of nitrogenous waste products leads to increased levels of urea and 
creatinine. 
If the kidney failure is persistent or chronic, then the impaired endocrine functions of the 
kidney manifest clinically with the development of anaemia (with its associated poor 
quality of life) and renal osteodystrophy. The net effect of renal failure in its advanced 
form is a poor quality of life in both cognitive and physical functions. Children with 



















1.2 Definition and staging of chronic kidney disease (CKD) 
Operationally, CKD is defined by the National Kidney Foundation (NKF) Kidney 
Disease Outcomes Quality Initiative (K/DOQI) as kidney damage persisting for ≥ 3 
months or Glomerular filtration rate (GFR) < 60ml/min/1.73m3, regardless of the 
underlying diagnosis.3 Kidney damage in this context is defined as structural or 
functional abnormalities of the kidney as identified by imaging tests(e.g. hydronephrosis, 
small hyperechoic kidneys, absence of one kidney), kidney biopsy, or abnormalities in 
the urine (e.g. proteinuria, microalbuminuria, haematuria) or blood (e.g. elevated blood 
urea or creatinine). Neonates with prenatal renal abnormalities detected on ultrasound 
that is confirmed postnatally have CKD because the kidney abnormality started in utero.4 
Thus all neonates with congenital kidney malformations in essence have CKD.  
The NKF-K/DOQI has classified CKD into 5 stages according to its severity as 
determined by the GFR with stage 1 disease being mild and stage 5 the most severe 
form.3 (Table 1). Since GFR increases with maturation from infancy and approaches 
adult mean value by 2 years of age, it is important to recognise that GFR ranges that 
define the CKD stages apply only to children 2 years and above. These GFR ranges 
defining CKD do not apply to infants, since they normally have a lower GFR, even when 
corrected for body surface area.3  
According to this nomenclature, patients with stage 5 disease are in end-stage renal 
failure (ESRF) and thus require a form of renal replacement therapy (RRT) in the form of 
dialysis or kidney transplant in order to ameliorate the toxic effect of uraemia, improve 
the quality of life and indeed, to sustain life. But epidemiological studies suggest that 
patients with ESRF represent just the “tip of the iceberg” of CKD and that patients with 
earlier stages of CKD (stage 1-4) are likely to exceed those reaching ESRF by as much as 
50 times.5  Since CKD is usually asymptomatic in its early stages, it is often 


























GFR(ml/min/1.73m2) Description Action plan 
      1     ≥ 90 Kidney damage with normal or 
increased GFR 
Diagnose and treat 
primary & comorbid 
conditions, slow 
CKD progression 
      2      60-89 Kidney damage with mild 
reduction of GFR 
Evaluate rate of 
decline in GFR 
      3      30-59 Moderate reduction of GFR Evaluate & treat 
complications 
      4       15-29 Severe reduction of GFR Prepare for renal 
replacement therapy 















1.3 Burden of CKD, cost implications and need for early detection. 
Worldwide, the number of patients with chronic kidney disease (CKD) is rising 
markedly, especially in adults, and CKD is now being recognised as a major public health 
problem that is threatening to reach epidemic proportions over the next decade.6 
The economic cost of North American ESRF programmes reached $25.2 billion in 2002, 
an 11.5% increase over the previous year, and is expected to reach $29 billion by 2010.6 
Given the high cost of treatment for patients in ESRF and the fact that 50 times more 
patients have milder kidney disease, the diagnostic and therapeutic approach to CKD 
must emphasise early detection, and aggressive management aimed at slowing the disease 
progression and avoiding ESRF. This is particularly important in children in whom 
congenital abnormalities of the kidney and urogenital tract are the main causes of 
CKD.7,8,9  Malformations of the urinary tract, obstructive uropathy, and renal 
hypoplasia/dysplasia is said to account for 36% of children with chronic renal failure 
worldwide.10   
1.4 Progression of CKD in PUV to ESRF 
The North American Paediatric Renal Transplant Cooperative Study (NAPRTCS)8 and a 
population-based registry in Italy (ItalKid)9 data have demonstrated that patients with 
congenital anomalies such as PUV have slower progression of early CKD towards ESRF 
than patients with glomerular disease as the underlying pathology for their CKD. 
Malformations of the urinary tract can easily be detected by antenatal ultrasound scan.  
Given the relatively high incidence of posterior urethral valves (PUV), 1 in 5,00011 to 1 
in 8,00012 live births, and the fact that early detection and therapeutic intervention can 












1.5 Motivation for the study: Importance of early detection and 
intervention of PUV in Africa.  
 
Africa is a developing country where the resources and expertise to manage terminal 
CKD are largely lacking. It is therefore of great importance to detect congenital 
malformations of the urinary tract at the earliest time possible so as to slow down the 
disease progression and possibly avoid the development of ESRF. 
This consideration formed the motivation for this study which looked at the management 
practices of children with diagnosis of PUV at Red Cross Children Hospital, particularly 
in auditing the timing of diagnosis and surgical intervention. The documentation of this 
particular experience at RXCH would therefore be very important in creating future 
direction for the best care of PUVs in developing countries. 
 
1.6 Research Question 
Red Cross Children Hospital (RXCH) is reputed to offer one of the best paediatric renal 
services in Africa. The renal unit has well laid out treatment protocols for the different 
categories of renal diseases aimed at offering comprehensive care including longitudinal 
follow-up. Children with PUV are followed up according to a PUV Protocol (Appendix 
2). 
This study sets out to address the following questions: 
• How many cases of PUV were diagnosed over the period January 2002 to January 
2009? 
• At what ages were PUVs diagnosed? 
• What were the timing and type of surgical interventions used? 
• Were there associated urinary tract abnormalities or medical conditions? 
• What were the courses of the disease over the time period? 
• Were there any factors of prognostic importance? 
• To what extent was the departmental protocol adhered in follow-up care? 












1.7 Study Objectives 
The study objectives are to: 
• document characteristics of patients (race and age at diagnosis) and 
clinical presentation of PUV 
• audit timing of diagnosis and surgical intervention 
• audit type of surgical procedure used in management 
• document associated urinary tract abnormalities  
• identify complications associated with PUV.  
• identify factors that portend poor prognosis  
• determine progression of kidney function deterioration at 1 year and at 
last follow-up 
• identify other medical conditions associated with PUV 
• determine the extent of adherence to  departmental protocol 
• determine outcomes 
 
1.8 Outline of the dissertation 
The work conducted in this study is presented in the various chapters. Chapter 1 gives 
background to PUVs, renal function and the effect of renal dysfunction, and the burden of 
chronic kidney disease that is becoming an epidemic. The pressing need for early 
detection and intervention is also highlighted. Finally, the motivation for the research as 
well as the research objectives is introduced in chapter 1. Chapter 2 reviews the subject of 
posterior urethral valve from valuable research papers and books. The research 
methodology used in this study is outlined in chapter 3. The research findings are 
presented in chapter 4. A detailed interpretation and discussion of the findings from this 
study in the light of current literature is presented in chapter 5. Conclusions drawn from 
this study as well as recommendations, and the limitations to the study are presented in 
chapter 6. All the references cited in this study followed the Vancouver style and are 
presented after chapter 6. Important documents and radiographs related to this study are 




















This chapter reviews posterior urethral valve from current updates, various studies in the 
literature, and valuable books. 
2.1 Structure and development of PUV 
The male urethra is composed of posterior and anterior urethral segments. The posterior 
urethra consists of the prostatic urethra and the membranous urethra whilst the anterior 
urethra consists of the spongy/penile urethra. Figure 2.1  
      PUV develops during embryogenesis when the mesonephric (Wolffian) duct insert 
abnormally anterior on the cloaca before its division into the urogenital sinus and the 
anorectal canal.2 Under conditions of normal insertion of the mesonephric duct, the most 
caudal end of the duct is absorbed into the primitive cloaca at the site of the future 
verumontanum in the posterior urethra. The remnants of this process are the posterior 
urethral folds called plicae colliculi that run distally and laterally to the verumontanum. 
The verumontanum is the midline prominence in the midprostatic urethra where the 
ejaculatory ducts enter. Abnormal anterior insertion of the mesonephric duct is thought to 
exaggerate the normal folds, with the distinction of these folds being thicker, more 









































2.2 Types/Classification of PUV 
Posterior urethral valve was first described and classified by Hugh Hampton Young, 
urology pioneer, in 1919.16 Young et al initially categorised PUV into 3 types: 
• Type I valves: these are bicuspid valves/leaflets that originate at the distal aspect 
of the verumontanum and fan out to fuse in the midline just proximal to the 
external striated sphincter. There is a variable aperture to allow urine flow during 
voiding; however, the fused portion fills with urine and bulges into the 
membranous urethra. This gives the characteristic sail-in-the-wind finding 
commonly seen on micturiting cystourethrogram (MCUG). Type I valves account 
for 95% of all valves. 
• Type II valves: are mucosal folds that run along the posterolateral wall of the 
urethra from the ureteral orifice to the verumontanum. Type II valves are no 
longer considered as obstructing valves; rather, they are thought to be sequele of 
voiding dysfunction. They can be differentiated from type I and III valves by their 
location proximal to the verumontanum. 
• Type III valve: is a circumferential membrane or diaphragm that is located at the 
membranous urethra and is thought to result from incomplete regression of the 
urogenital membrane during embryogenesis. There is a central aperture, and the 
central portions of the ring may prolapse into the more distal urethra during 
voiding, which results in a wind-sock appearance on MCUG. Type III valves 
















2.3 Pathophysiology/Effects of PUV on the urinary system 
Compared with the adult kidney, the developing kidney is highly susceptible to injury 
from obstruction to urine flow as occurs in PUV.17 PUV can appear at the earliest stage 
of development of the urinary system; therefore, the entire developing kidney and the 
urinary tract develop in an abnormal environment of high intraluminal pressure due to the 
mechanical obstruction.2 The occurrence of such obstruction at a critical time in 
organogenesis can have a profound and permanent effect on the functions of the kidneys 
(glomerulus, tubules, microvasculature, interstitium), ureters, and the bladder.2,18 The 
consequence of such profound and permanent defect on the developing urinary system is 
that significant malfunction of the kidneys, ureters and bladder may persist despite 
adequate decompression of the urinary tract. Not surprisingly, therefore, attempt at in 
utero drainage of the urinary tract through vesicoamniotic shunts at periods when foetal 
viability can be assured has been met with unfavourable results.19,20,21 To the contrary, 
other studies22 have shown clear benefit of early surgical intervention in slowing 
progression to ESRF. The outcome of surgical intervention is to a large extent determined 
by the gestational age of the foetus when obstruction developed, and by the presence of 
renal dysgenesis (abnormal development of the kidneys). 
2.3.1 Effect on the kidney 
Renal parenchymal dysgenesis (dysplasia and hypoplasia) is commonly present in 
patients with PUV and may be due to maldevelopment of the metanephric blastema in an 
environment of high intraluminal pressure.2,23,24 Experimental models in animal studies 
have shown that even temporary complete unilateral ureteral obstruction during 
nephrogenesis or during nephron maturation can permanently reduce the number of 
nephrons in the obstructed kidney leading to hypoplasia.25,26 The kidneys in PUV may 
















2.3.2 Effect on the tubulointerstitium 
The hallmarks of chronic severe obstructive uropathy are the development of tubular 
atrophy and interstitial fibrosis.27 Tubular atrophy results from progressive destruction of 
tubular epithelial cells by programmed cell death (apoptosis).27 Factors contributing to 
tubular apoptosis include mechanical stretch of epithelial cells in the dilated tubules, as 
well as altered gene expression. 18,27 The expression of epidermal growth factor (a 
survival factor) by the renal tubular cells is reduced, whereas expression of transforming 
growth factor-β (TGF- β), a proapoptotic factor, is increased, the balance being tipped in 
favour of cell death. The results is progressive loss of renal mass.28 Chronic unilateral 
ureteral obstruction has been shown to lead to infiltration of the interstitium by 
macrophages and fibroblasts which release fibrogenic cytokines such as TGF-β leading to 
interstitial fibrosis. The stretched tubular cells themselves under the influence of local 
growth factors, cytokines and chemokines can undergo epithelial-mesenchymal 
transformation and differentiate into fibroblasts that augment the progression of 
interstitial fibrosis.29,30 
Renal hypoplasia/dysplasia, tubular atrophy, and interstitial fibrosis is commonly 
associated with PUV. In a study of children with PUV, Heuser and Landing31 
demonstrated that hypoplasia/dysplasia, tubular atrophy, and interstitial fibrosis was 
present in 39/41 (95.1%) nephrectomy samples.  
 
2.3.3 Impact on tubular function 
The consequence of tubular atrophy and interstitial fibrosis as explained above is 
impaired resorptive capacity of the kidneys. In addition to this tubulo-interstitial defect 
that distort the medullary architecture, down-regulation of sodium transporters and 
aquaporins have been described in chronic obstructive uropathy.32,33 The consequence is 
poor urinary concentrating ability, resulting in polyuria. These factors contribute to the 











bilateral urinary tract obstruction such as PUV.33 Since positive sodium balance is 
necessary for normal somatic growth in infancy, impaired growth is another consequence 
of reduced sodium reabsorption in PUV.34 Thus infants with obstructive uropathy may 
require sodium supplementation to optimise somatic growth. Distal tubular secretion of 
potassium and hydrogen ion may also be impaired leading to type 4 renal tubular 
acidosis.35   
 
2.3.4 Effect on ureters and urinary bladder 
The bladder outlet obstruction that occurs in PUV, coupled with the high urinary 
production, places considerable strain on the bladder and ureters. Firstly, the bladder 
undergoes hypertrophy and hyperplasia in response to the increased workload generating 
high voiding pressures with near complete emptying initially. There is also increase in 
collagen deposition. The increased voiding pressures may be transmitted to the upper 
tract, resulting in dilatation of the ureters, pelvis and calyces, and to the glomeruli 
contributing to the renal damage. The hypertrophied and hyperplastic bladder may have 
altered blood flow to the detrusor muscle leading to ischaemic damage and further 
alteration in collagen deposition.2 Several authors have noted high pressure, poorly 
compliant bladder sometimes with uninhibited contraction of the detrusor muscle which 
may eventually lead to myogenic failure.2 The term “valve bladder” is used to describe 
the bladder of patients with PUV who have a fibrotic, poorly compliant bladder. Milder 
cases may present with isolated urinary incontinence. 
There are several causes for dilated ureters which occur in association with PUV. 
Hydroureter may develop secondary to high retrograde pressure caused by bladder 
dysfunction. High pressure and large urine volumes may also contribute to deficient 
muscle development in the walls of the ureters. Large urine volumes due to poor 


















2.3.5 Adaptive mechanisms in PUV 
The impact of urinary tract obstruction may de distributed unequally between the two 
kidneys.27 For example; hydroureteronephrosis may occasionally be limited to one side 
with associated ipsilateral vesicoureteric reflux and dysplastic kidney whilst the 
contralateral kidney develops normally. This protective mechanism called vesicoureteral 
reflux and renal dysplasia (VURD) syndrome allows one unit to absorb the brunt of the 
high pressure and is thus lost in the process while the other unit is spared and undergoes 
compensatory hypertrophy.2,36 Other adaptive mechanisms to absorb the high pressure 
(pop off mechanisms) in PUV include bladder diverticula and urinary ascites resulting 
from rupture of a calyx.   
 
2.4 Prevalence  
The prevalence of PUV worldwide is quoted at between 5,000 2,11 to 8,000 12 live births. 
It is estimated that 10-15% of children undergoing kidney transplantation worldwide 
have PUV as the cause of their ESRF.37 
 
2.5 Race 
Though some authors report of no racial predilection,2 Meyers et al38 reported of 
increased prevalence among black children in South Africa. 
 
2.6 Sex 
PUV affects only males.1 The female homolog to the male verumontanum from which 


















2.7 Clinical presentation of PUV  
The clinical presentation of PUV is extremely variable which may be related to the 
degree of obstruction.2 In the presonography era, late presentation of PUV was 
considered a good prognostic sign suggestive of a lesser degree of obstruction. Over the 
past 2 decades, however, the widespread use of prenatal ultrasound in developed 
countries has resulted in most cases of PUVs being diagnosed antenatally.39 Currently, 
congenital obstructive uropathy is diagnosed before the age of one year in almost 100% 
of cases. Early diagnosis and early surgical intervention to relieve obstruction, combined 
with coordinated medical and surgical follow up, has resulted in a significant decline in 
infant mortality from obstructive uropathies such as PUV.37 
 
2.7.1 Features on prenatal ultrasound scan 
The classical features on antenatal scan include oligohydramnios, bilateral 
hydronephrosis and hydroureter, a thick-walled bladder with or without diverticula, and a 
dilated urethra.1 The oligohydramnios may result in marked pulmonary hypoplasia 
causing death shortly after birth, while others already succumb in utero. When a male 
newborn is found to have bilateral hydronephrosis and hydroureter, he should be 
regarded as having PUV until proven otherwise.1  
 
2.7.2 Clinical presentation in the newborn 
Newborns with PUV may present with respiratory distress due to underdevelopment of 
the lungs (pulmonary hypoplasia) caused by oligohydramnios. An appropriate volume of 
amniotic fluid largely produced by foetal urine is necessary for complete and proper 
branching of the bronchial tree and alveoli. Other consequences of oligohydramnios 
include Potter’s facies and limb deformities. Abdominal distension from urinary ascites 
or urinoma due to calyceal rupture, and a palpable abdominal mass from hydronephrosis 
or distended urinary bladder may are additional features.2,40  
If the diagnosis of PUV is not recognised at birth, then severely affected children often 










abnormalities, renal failure or failure to thrive.2 A poor, dribbling urine stream may also 
be noted. The UTI may rapidly disseminate into urosepsis as the infection occurs within 
the closed system of PUV.1 
     
2.7.3 Presentation in infants and toddlers 
For children who escape prenatal detection, PUVs are usually discovered during 
evaluation of UTI, voiding dysfunction, failure to thrive, abdominal mass, or renal 
failure.1,2  
 
2.7.4 Delayed presentation in older children and adults 
Children with PUV that were not diagnosed on prenatal ultrasound and who do not 
manifest overt urinary pathology are at risk of delayed presentation. As stated earlier, 
such children have been assumed to have milder degree of obstruction. But as expected, 
such children have often presented in advanced renal failure when much of their function 
has been lost. Such presentations include UTI, urinary incontinence, particularly daytime 
wetting in boys older than 5 years, secondary diurnal enuresis, voiding pain or 
dysfunction, and poor urine stream. Others may be diagnosed incidentally when 
proteinuria or hydronephrosis is found on examination for unrelated conditions. 
Though rare, adult presentation of PUV has been described with symptoms varying from 
obstructive voiding symptoms to postejaculatory dysuria.37 
 
2.8 Diagnosis 
2.8.1 Renal and bladder ultrasound scan 
Ultrasound is a useful screening tool for all children with suspected PUV. A proper 
ultrasonographic study to evaluate the urinary tract must include images of kidneys, the 
ureters, and the bladder (KUB). For every child in whom PUV was suspected based on 
antenatal hydronephrosis, renal and bladder ultrasound scan should be performed in the 
early postnatal period to confirm the hydronephrosis and look for additional features of 
PUV. Typical findings on ultrasound suggestive of PUV include bilateral 
hydroureteronephrosis with or without cortical thinning, thick-walled bladder with 










neck2. The bladder may be of large or small volume, but it is invariably thick-walled. 
Occasionally, the hydroureteronephrosis is limited to one side with associated cystic or 
dysplastic-appearing kidney which also has vesicoureteric reflux in what is termed 
vesicoureteral reflux and renal dysplasia syndrome (VURD). VURD is an adaptive 
response in which one unit of the urinary system absorbs the brunt of the high pressure 
and is lost while the other unit is spared and undergoes compensatory hypertrophy. 
Ultrasound may also pick up complications that may be associated with PUV such as 
urinary ascites, perinephric collections due to urinomas, and bladder diverticula. These 
complications act as pop-off mechanisms to also absorb the pressure in the system. 
Additionally, the parenchyma of the kidney will also be assessed by ultrasound for any 
evidence of hypoplasia and dysplasia which appear as small kidneys, or hyperechogenic 
kidneys with small cysts respectively. These numerous findings on ultrasound 
notwithstanding, micturiting cystourethrogram is necessary to confirm the diagnosis of 
PUV since ultrasound findings may be normal in mild cases without upper tract 
abnormality and an essentially normal bladder.2 Bomalaski et al37 found as many as 30% 
of their patients with PUV who had late presentation to have a normal ultrasonography. 
These cases could all be considered mild as they presented late.  
2.8.2 Micturiting cystourethrogram (MCUG) 
MCUG is considered the diagnostic criterion standard imaging modality for PUV.2 It is 
important to perform the MCUG during voiding and under fluoroscopy, with imaging of 
the posterior urethra. The diagnosis of PUV on MCUG is confirmed by visualisation of 
the valve leaflets and a dilated or elongated posterior urethra. MCUG also assesses the 
bladder for associated findings of trabeculation, diverticula, and vesicoureteral reflux 
(VUR). Figure 2.2 
2.8.2.1 Limitations of MCUG 
Sometimes, normal mucosal folds of the posterior urethra (plicae colliculi) may appear as 
luscencies on MCUG and suggest the presence of valve leaflets. Conversely, valve 
leaflets may not be visible on MCUG particularly if improper MCUG techniques are 
used; such as omission of adequate urethral views during voiding or failure to remove the 






















Figure 2.2: MCUG in a child with PUV showing a dilated posterior urethra, 















The limitations of MCUG make it imperative, sometimes, to resort to cystourethroscopy 
to either confirm or negate the diagnosis of PUV.2,40 Cystourethroscopic confirmation of 
PUV should be combined with primary valve ablation. 
 
2.8.4 Other diagnostic tools in PUV 
Computed tomography scan and magnetic resonance imaging have sometimes been 
employed in the diagnosis of PUV but these offer no diagnostic advantage over MCUG 
except for the rare instance where plicae colliculi are demonstrated with  MCUG and not 
with computed tomography and which may then lead to an incorrect diagnosis of PUV. 
Nuclear cystography has no role in the diagnosis of PUV. Nuclear renography, however, 
may be used to assess upper tract consequences of bladder outlet obstruction and to 
determine relative function of each kidney.2 
Urodynamic studies are frequently employed to evaluate bladder function. 
 
2.9 Differential diagnosis of PUV 
These include anatomic obstructive disorders and functional voiding disorders.2 
Anatomic obstructive disorders: 
• Urethral atresia 
• Anterior urethral valves 
• Urethral duplication 
• Congenital urethral polyp 
• Ureterocele 
• Congenital urethral stricture (Cobb collar) 
• Prune-belly syndrome 
• Plicae colliculi (normal anatomic structure) 
Functional voiding disorders 
• Neuropathic bladder 











• Nonneurogenic neurogenic bladder (Hinman syndrome) 
• Small capacity hypertonic bladder 
2.10 Treatment of PUV 
Treatment of PUVs is broadly divided into medical and surgical care. 
2.10.1 Medical care 
Though corrective surgery remains the definitive treatment of PUV,1,40,41 some children 
may present in metabolically unstable state with severely impaired renal function, 
electrolyte and acid-base abnormalities, dehydration, or infection that requires initial 
medical stabilization.1,40 Newborn babies with severe PUV may require pulmonary 
resuscitation due to pulmonary hypoplasia. Under such circumstances, immediate relief 
of urethral obstruction should be instituted by placement of urethral catheter either 
transurethrally,1,40 or suprapubically through a wide intravenous canula.1 This will allow 
drainage of the obstructed system, may improve renal failure, reduce risk of infection as 
well improve treatment response, and thereby reducing the opportunity for further renal 
damage.1 After relief of the obstruction there will often be a diuretic phase as a 
consequence of the associated tubular dysfunction and solute diuresis, resulting in salt 
and water loss which will require careful replacement and monitoring for some days.  
      The second phase of medical management of PUVs is follow-up care after surgical 
intervention. Unrelenting progression of renal dysfunction has been widely associated 
with some cases of obstructive uropathy even after surgical correction that requires long-
term follow-up and optimal care so as to slow the progression. Areas of particular 
importance include prevention and efficient treatment of UTI, blood pressure control, 
monitoring for and control of proteinuria, optimal management of renal failure, and 
management of bladder problems. Identification and management of any bladder 
dysfunction is particularly important as it has implications for graft survival following 
transplant. Thus, urodynamic studies should be considered in any boy with PUV with 
suspected bladder dysfunction. In general, urinary incontinence beyond the age of 5 years 
should prompt evaluation of bladder dysfunction.1  The fibrotic, poorly compliant bladder 
that is often associated with severe PUV require optimal management with 
anticholinergics, clean intermittent catheterization with or without continent 













2.10.2 Surgical intervention 
Surgery remains the definitive treatment of PUV to ablate this congenital membrane. 
However, in certain situations primary valve ablation may have to be deferred. In such 
situations, urinary diversion procedures will have to be performed to provide a more 
lasting drainage of the obstructed system beyond that provided by the initial 
catheterization. Surgical management of PUV is thus divided into 2;  
• Corrective surgery 
• Urinary diversion 
2.10.2.1 Corrective surgery 
Primary valve ablation is the treatment of choice in PUV42 and is recommended soon 
after confirmation of PUV. Various surgical approaches that have been described 
include:40  
• disrupting the obstructing membrane by the blind passage of a valve hook.  
• rupture of the valves with a Forgarty catheter under radiologic control 
• a perineal urethrostomy approach particularly when there are difficulties with 
instrumentation 
• Direct transvesical approach  
• Diathermy of the valves with a D. I. W. Hook especially in the preterm infant 
Currently, however, valves are disrupted under direct vision by urethrocystoscopy using 
an endoscopic loop, Bugbee electrocauterisation, or laser fulguration.1,2 The objective is 
to relieve the obstruction by cutting the valves at the 12-, 5-, and 7- o’clock positions. 
2.10.2.2 Urinary diversion 
Urinary diversion may be used in situations where primary valve ablation is not feasible 
e.g. urethral size too small for available cystoscopic instrumentation. In such situations, 
valve ablation is deferred until adequate growth of the urethra has occurred, usually by 
age 1 year. The diversionary stoma is then closed when secondary valve ablation is 
carried out.  Three methods of urinary diversion have been described and they may be 












• Bilateral cutaneous ureterostomies40,42 
• Nephrostomy40,42 
2.11 Long term outcome of PUV 
Several studies have confirmed that children with PUV progress to ESRF, albeit slowly, 
despite corrective surgical intervention.1,41,43,44 This calls for a prolonged and coordinated 
medical and surgical follow-up care so that evolving clinical problems can be identified 
and managed early so as to slow progression. Several factors account for this progressive 
nature of renal insufficiency in PUV. As enumerated under section 2.3 above, the 
obstructive pathology occurring in intra-uterine life during critical period of 
nephrogenesis leads to parenchymal dysgenesis and nephron loss. These children are 
therefore born with reduced renal reserve and are at risk of CKD particularly during 
adolescence when the increase in body mass places enormous metabolic burden on the 
stressed kidney. Bladder dysfunction as well as ureteral abnormalities that are commonly 
associated with PUV may contribute significantly to deteriorating renal function if they 
are not identified and managed optimally.   
 
2.12 Prognostic factors 
Factors that have been cited as portending poor long-term outcome in PUV include: 
• Early presentation outside prenatal detection.45 It is argued that severe obstructive 
disease will manifest early in life 
• Nadir serum creatinine > 80 µmol/l at 1 year of age after relief of obstruction.46,47 
or within 5 days of relief of obstruction 
• Proteinuria at age 5 years.45 
• Daytime incontinence after 5 years of age, indicating bladder dysfunction.45 
 
Identification of these prognostic factors may be useful in planning further management 















STUDY SUBJECTS AND METHODS 
3.0 Introduction 
This chapter captures the description of the study site and the study design. Statistical 
tools used in data collection and analysis, and ethical issues in this study are also 
described in this chapter 
3.1 Study site 
The study was carried out at Red Cross Children Hospital (RXCH), Cape Town, South 
Africa. 
South Africa is the southern-most part of Africa with a total land area of 1,219,090 
square kilometres.48 It has only northern borders, being bordered from north east to north 
west by Mozambique, Zimbabwe, Botswana, and Namibia. Figure 3.1 Uniquely, South 
Africa shares 2 oceans in its coast; the Atlantic Ocean and the Indian Ocean. It has 9 
administrative provinces (Figure 3.1) with a total national population of 40.5 million.48
It is a multiracial country consisting of Blacks, Whites, Coloured, Asians, and others 
unspecified.   
Cape Town is the provincial capital of the Western Cape, where RXCH is located. The 
dominant racial group in the Western Cape are the Coloured with a population of 
2,146,109 (54.2%) out of the provincial total of 3,956,875. The black and the White form 
almost equal proportion of 20.8% and 20.7% respectively, corresponding to nominal 
figures of 826,691 and 821,551. Asians constitute 40,376 (1.0%) of the provincial total of 
3,956,875. Table 3.2 
Red Cross Children Hospital is a specialist, teaching hospital affiliated to the University 
of Cape Town. It serves as the main tertiary referral center to the whole of the Western 
and Northern Cape Provinces and also receives referrals from other provinces and 
abroad. It has units for all the major paediatric sub-specialist disciplines and has a total 











recently, it was the only center where paediatric combined kidney-liver transplantation 
was done. It thus receives referrals from all over the country and beyond.  
Children with posterior urethral valves are followed up according to a departmental 
protocol. See Appendix 2.   
The renal unit combines harmoniously with the urology and radiology units through a 
weekly joint renal-urology ward round and a weekly renal-urology and radiology 
conference. Such collaboration affords the opportunity for joint treatment approach for 



















































































































































































































3.2 Study Design 
This was a retrospective study of all children with diagnosis of PUV who were captured 
on the hospital’s database from the period January 2002 to January 2009. 
 
3.2.1 Inclusion criteria 
• All patients with diagnosis of posterior urethral valve, as established by 
micturating cystourethrogram or urethrocystoscopy, who were captured on the 
hospital’s database from January 2002 to January 2009.  
 
3.2.2 Exclusion criteria 
• Causes of bladder outlet obstruction other than PUV 
• PUVs hooked to the database after 31st January, 2009. 
 
3.3 Method of data collection 
The medical records of all children who satisfied the inclusion criteria were retrieved. A 
case report form (Appendix 3) was used for data capturing. Information extracted from 
the records included: 
• age at which diagnosis was suspected 
•  race 
•  clinical presentation 
• time interval to confirmation of diagnosis  
• time interval between confirmation of diagnosis and surgical intervention 
• type of surgical procedure used to relieve obstruction 
• documented complications associated with PUVs 
•  co-morbid conditions identified 
• serum creatinine values at time of diagnosis, nadir value after surgical relief of 











• Outcome of patient at last follow up in terms of stage of chronic kidney disease, 
renal replacement therapy, and patient’s survival. 
 
3.4 Estimation of glomerular filtration rate (eGFR) 
The GFR of study subjects were estimated from the Haycock - Schwartz formula49 as 
follows: 
 
 eGFR(ml/min/1.73m2)  =  k  x  height (cm)/serum creatinine (µmol/l) 
                      
where k                                                 =  24  for preterm neonates 
                                                                 33 for term neonates 
                                                                 40 for normal infants (0 – 12 months) 
                                                                 49 for boys and girls (2-12 years)    
                                                                 49 for girls 13 – 21 years 




3.5 Data management and analysis 
After completion of the datasheet, the data was double entered using Epi info version 
3.2.2. It was checked for inconsistencies on a weekly basis. Upon completion of the data 
entry, data was transported to Stata® intercool version 10 for analysis. Continuous 
variables such as the age at diagnosis and length of follow-up were analysed and reported 
as median with their inter-quartile range. Categorical data were analysed and presented as 
frequencies with their respective percentages. Spearman’s correlation was used to 
determine the correlation between the stage of kidney disease and the various continuous 
variables. For dichotomous variables however, the chi-square tests for trend was used.  













3.6 Ethical Consideration 
3.6.1 Access 
Ethical approval (REC REF: 061/2009) was obtained from the Faculty of Health Sciences 
Research Ethics Committee of the University of Cape Town. Appendix 4. Written 
approval to perform the research was obtained from the medical superintendent of 
RXCH. Appendix 5.   
3.6.2 Ethical Principles guiding the conduct of the research 
To ensure maximum protection and confidentiality of patients who were enrolled into this 
study, patient names were not included on the case report forms. Data collected from 
each study subject was kept in a binder in a locked cabinet. Data entered into the 
computer were not released to others except the statistician who was in a foreign country. 
The foreign location of the statistician together with the anonymous label of the data 

















4.0 Study subjects 
A total of forty-nine children with the diagnosis of posterior urethral valve were analysed 
over the study period. A review of one child however showed that he had idiopathic 
urethral bulbar stricture, and not PUV. He was subsequently excluded from the study. 
Forty-eight children were thus eligible for analysis. 
 
4.1 Age at diagnosis 
Nineteen (39.6%) out of the 48 study subjects had the diagnosis of PUV made by prenatal 
ultrasound scan whilst the remaining 29 (60.4%) were diagnosed postnatally. Age at 
diagnosis in the latter group ranged from 1day to 2,950 days. The mean age at diagnosis 
was 241.2 days and the median age was 17days (IQR 1.0 – 90.5 days).  
On the whole, 22 (75.8%) of the 29 postnatally diagnosed cases were diagnosed within 1 
year of age. 
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4.2 Race of study subjects 
The prevalence of PUV among the various racial groups was as follows: 
Thirty four of 48 patients (70.83%) were of the Coloured race whilst 13 (27.01%) were 
Blacks. Only one subject (2.01%) was White. There were no Asian patients. Figure 4.2.  
 
 




























4.3 Method of diagnosis of PUV 
Three main diagnostic investigatory methods of PUV were identified in this analysis; 
ultrasound, MCUG, and urethrocystoscopy. All cases had kidney, ureter, and bladder 
(KUB) ultrasound done largely as screening method. The study subjects would then 
subsequently have MCUG to confirm the diagnosis. The diagnoses of 3 cases were 
however based solely on ultrasound studies. In 1 case, MCUG could not confirm the 
presence of the valves when the KUB ultrasound had suggested PUV. PUV was however 
confirmed on urethrocystoscopy. 
 
4.4 Time interval to confirmation of diagnosis 
The median time interval from clinical suspicion of PUV and/or ultrasound screen to 
confirmation by MCUG and/or urethrocystogram was 5 days (median 5, IQR 1.0 – 10.2 
days). In seventeen (35.4%) of the 48 cases, the diagnosis was confirmed within the first 
24 hours of life. In 32 patients (66.6%), the diagnosis was confirmed within the first 7 
days of initial suspicion and in 2 patients (4.1%) after 30 days.  
 
4.4.1 Some reasons for delayed MCUG confirmation 
Some reasons that were identified for delayed confirmation of PUV by MCUG were: 
• Fluoroscopic machine has broken down  
• Patient missed appointment 
• On-going urinary tract infection 
 
4.5 Time interval to primary surgical intervention 
The median time interval from confirmation of PUV to primary surgical intervention was 
8.5 days (IQR 6 - 15days). Except for 2 cases whose surgery were delayed beyond 30 
days at 40 and 120 days respectively, all cases (95.8%) had primary surgical intervention 
within the first 30 days of confirmation of PUV.  
4.5.1 Some reasons for delayed primary surgery 











• Urethra too small for the available cystoscope 
• On-going urinary tract infection  
Interestingly for one particular child, the initial MCUG was postponed due to breakdown 
of the Fluoroscope. When it was fixed and the diagnosis was confirmed on MCUG, an 
attempted valve ablation was unsuccessful due to hypertrophied bladder neck. He had to 
be rescheduled again for temporary urinary diversion by vesicostomy and only had valve 
ablation done at a later date. 
 
4.6 Treatment of PUV 
4.6.1 Initial medical management 
It is the practice at this study site to insert an initial urinary catheter in all cases of 
suspected obstructive uropathy secondary to PUVs. Thus all cases of PUV identified in 
this audit had initial transurethral catheter placement to drain the urinary tract while 
awaiting confirmation. Screening and treatment for urinary tract infection was routinely 
done. MCUG was done only after the UTI has been well treated. The electrolyte and 
acid-base abnormalities that were associated with the renal failure were treated according 
to standard treatment of renal failure. Intravenous fluid replacement was done for post-
obstructive diuresis according to the age-specific urine output/kg/hr.  
Since Red Cross Children’s Hospital had no neonatal unit, all cases with initial 
respiratory problems at birth were firstly managed at the neonatal intensive care unit at 
the provincial maternity hospital. 
 
4.6.2 Type of surgical intervention 
Three types of surgery were identified in the management of PUV in this study either 
alone or in combination;  
• Valve ablation 
• Vesicostomy 
• Cutaneous ureterostomies 
 
Thirty-five (72.9%) out of the 48 cases had valve ablation as the primary surgical 











vesicostomy. Secondary vesicostomy was performed on 3 cases on account of incomplete 
primary valve ablation. Four (8.3%) out of the 48 cases had secondary cutaneous 
ureterostomies to augment urinary drainage on account of secondary vesicoureteral 
junction obstruction.  
Two children had their valves ablated incidentally during passage of urethral catheter; 1 
completely and the other partially. 




Table 4.1: Types of surgical interventions in treatment of PUV 
 
Type of Surgery Frequency Percentage 
 
Valve ablation only 
            
          29 
 
               60.4 
 
Primary vesicostomy only 
             
           12 
 
                 25.0 
Valve ablation + secondary 
ureterostomies 
              
             3 
 
                 6.3 
Valve ablation + secondary 
vesicostomy 
             
             3   
 
                6.3 
Primary vesicostomy + 
secondary ureterostomies 
            
             1 
 




            48 
 
                 100.0 

















4.6.3 Other surgical interventions 
Besides the definitive treatment of valve ablation and temporary diversionary methods, 
other surgical interventions that were carried out in patients’ management included: 
• Bladder augmentation (2 cases) 
• Appendicovesicostomy (Mitrofanoff principle) for CIC of the bladder (2 cases) 
• Nephrectomy for non-functioning kidney ( 2 cases), and severe pyonephrosis (1 
case) 
 
Histology of the 3 nephrectomised kidneys showed renal dysgenesis with interstitial 
nephritis in two, whilst the other showed end stage renal disease with hydropyonephrosis 
from long standing hydronephrosis and pyelonephritis.  
 
4.7 Primary Methods of Clinical Presentation 
 
The 48 cases of PUVs studied in this audit presented variably with some presentations 
unrelated to the urinary system. The various modes of clinical presentation are shown in 
Table 4.2. 
It is significant to note that dribbling of urine on micturition as a presenting complaint 



















Table 4.2: Methods of Clinical Presentation of PUV* 
Clinical Presentation Frequency        Percentage 
Prenatal hydronephrosis               17            35.41 
UTI               10             20.83 
Palpable abdominal mass 4             8.33 
Voiding difficulties 3             6.25 
Gastroenteritis 3              6.25 
Renal cysts detected on ultrasound 2             4.17 
Enuresis 2              4.17 
E. coli sepsis 1              2.08 
Meningitis 1              2.08 
Necrotising enterocolitis 1              2.08 
Pneumonia 1               2.08 
Renal failure 1              2.08 
Failure to Thrive 1              2.08 
Upper respiratory infection 1              2.08 
Total 48             100.00 
* The clinical presentation identified in this audit may be biased due to the absence of
neonatal unit at RXCH. Thus patients with severe symptoms related to pulmonary


















4.8 Associated urinary tract abnormalities 
 
Every segment of the urinary tract from the posterior urethra through the bladder, ureters, 
and the renal pelvis were affected in all the 48 cases studied. The renal parenchyma was 
not spared the secondary effects of this obstructive disease with 6 (12.5%) cases of renal 
dysplasia being recorded. Thirty-eight (79.1%) of the 48 cases had bilateral 
hydroureteronephrosis whilst 4 (8.3%) had unilateral pathology. Thirty-six (75.0%) had 
demonstrable bladder pathology of various degrees ranging from thickened wall through 
trabeculations to formation of diverticula. Thirteen (27.0%) cases had vesicoureteric 
reflux which could be demonstrated on MCUG whilst 6 (12.5%) cases had dysplastic 
kidneys, 2 of which were associated with unilateral VUR in Vesicoureteral Reflux and 
Dysplasia syndrome (VURD). 
The various abnormalities of the urinary system that were associated with PUV are 























































































































Complications of PUV identified in this audit were: 
• Urinary ascites (3) 
• Urinoma (2) 
• Oligohydramnios with lung hypoplasia (2) 
• Unilateral non-functioning kidney (2) 
• Potter’s sequence (1) 
• Perinephric abscess (1) 
• Pyonephrosis (1) 
• Acute renal failure (1) 
• Hypertension (1) 
• Ruptured bladder during MCUG (1) 
 
 
4.10 Other associated medical conditions 
Other medical conditions that were identified to be associated with PUV in this study are 
presented below: 
• Inguinal hernia (3 cases) 
• Bilateral squint (1 case) 
• Attention Deficit Hyperactive Disorder (1 case) 
• Polydactyly (1 case) 
• Trisomy 21 (1 case) 
• Dysmorphism with macrocephaly, mental retardation and atrial septal defect (1 
case) 
• Maternal systemic lupus erythematosis (1 case) 











• Pulmonary tuberculosis (1 case) 
 
4.11 Serum creatinine estimations 
 
4.11.1 Creatinine at diagnosis (pre-surgery) 
Records of serum creatinine at diagnosis (pre-surgery) were available for 40 (83.3%) out 
of the 48 studied subjects. The median creatinine value was 86 µmol/l (IQR 67.5 - 
146.7µmol/l). 
 
4.11.2 Nadir serum creatinine  
The lowest level of serum creatinine (nadir) achieved in the first year following surgical 
drainage ranged from 21µmol/l to 146 µmol/l with a median value of 40 (IQR 31.2 - 49.5 
µmol/l). 
 
4.11.2.1 Duration to nadir creatinine 
The time interval to achieve the nadir value ranged from 4 days to 210 days, with a 
median of 30 days (IQR 14.0 – 48.5 days). 
 
4.11.3 Serum creatinine at 1 year of age 
Records for serum creatinine at age 1 year were available for 18 (39.1%) out of the 46 
study subjects who were aged ≥ 1 year. The median value was 48 µmol/l (range 25 – 219, 





















4.11.4 Serum creatinine at last follow up 
Thirty-nine (81.2%) of the 48 study subjects had their creatinine determined at the last 
follow up. The median value was 57µmol/l (IQR 43-73µmol/l). 
 
4.12 Length of, and age at, follow up 
The median duration of follow up was 52 months (IQR 24 - 107 months).  
At the last follow up, patients’ ages ranged from 1 month – 221 months (median 100, 
IQR 47.5 – 128.7%).  
 
4.13 Outcome of study subjects 
4.13.1 Stage of chronic kidney disease 
The stage of chronic kidney disease at last follow up based upon the estimated glomerular 
filtration rate (GFR) according to the K/DOQI guideline are presented in Figure 4.4 
below. Staging of CKD could be determined for 37 (77.0%) out of the 48 study subjects. 
Two children were < 2 years and were therefore not eligible for CKD staging according 
to K/DOQI guidelines.3 For nine (19.5%) others, the eGFR could not be determined 
because of incomplete data; either lack of height measurement or no determination of 
serum creatinine at the last follow up. 
At the end of the follow up period, only one (2.7%) patient had reached ESRF at a time 






















One Two Three F our F ive
Figure 4.4: Stage of chronic kidney disease at last follow up 
 4.13.2 Type of Renal Replacement Therapy (RRT) 
The sole patient who had reached ESRF and therefore needed RRT had peritoneal 
dialysis for 5 months and was successfully transplanted thereafter at age 5 years 9 
months. The transplanted kidney has survived 4 years 2 months with a serum creatinine 
at last follow up of 48 µmol/l. 
4.13.3 Survival outcomes 
No mortality had been recorded in the cases reviewed during the study interval. However, 
for 14 cases, more than 1 year has elapsed since they were last reviewed. Their 
appointment schedules could not be determined from their folders to know whether they 
were still within appointment time or have defaulted follow up. The survival outcome of 











4.14 Correlation of various parameters of patients with the stage of 
CKD. 
Tests for correlations between various aspects of patients’ characteristics and stage of 
CKD were performed using either Spearman’s rank correlation or Chi (X-) squared. The 
results are presented in Table 4.3 below. 
 










p - value 





         -  
 
  0.592 (NS) 
 
Age at surgery 
 
 0.06209948  
 
         - 
 
  0.719 (NS) 
Presence of bladder 
pathology 
 
         - 
 
    1.0676     
 
  0.301(NS)  
 
Presence of VUR 
 
         - 
 
    0.2385 
 
  0.625 (NS) 
Serum creatinine at 
diagnosis(presurgery) 
 
 0.4563161    
 
          - 
 
  0.008* 





          - 
 
  0.003* 





          - 
 
  0.458 (NS) 
Serum creatinine at 1 
year 
  
 0.6815544  
 
          - 
 
  0.002* 
 
NS = not significant 


















4.15 Adherence to departmental protocol on PUV  
The departmental protocol on follow up management of children with PUV (see 
Appendix 2) stipulates a scheduled annual review tied with various investigations aimed 
at staging the CKD for the appropriate therapeutic action to be instituted as per K/DOQI 
guidelines (Table 1).  
This well scheduled follow up protocol was largely not adhered to. For example, only 25 
(54.3%) of 46 children aged ≥ 1 year were scheduled for the 1 year follow up 
appointment of whom 18(72%) had their serum creatinine determined. Height 
measurements, which serve both as index for growth monitoring and a factor in the 
computation of the estimated glomerular filtration rate (see Schwartz formula in section 
3.5), were inconsistently taken. For example, 9 patients (25%) had no height 

























5.0   Age at diagnosis of PUV and the need for universal prenatal 
ultrasound scan. 
For all forms of obstructive uropathies including PUVs, the goal of therapy is to relieve 
the obstruction in the earliest possible time. Such a goal can only be met if the condition 
is diagnosed early. Since urinary tract dilatation is generally regarded as one of the foetal 
abnormalities that could easily be identified prenatally, the tendency in the present 
decade in most first world countries is towards a 100% diagnosis of all obstructive 
uropathies prenatally.37,38,50  In developing countries, however, the often poor maternal 
health care services with its attendant lack of prenatal ultrasound scan leaves most 
children with obstructive uropathies to be identified only postnatally; sometimes quite 
late with advanced renal dysfunction. In this audit, more than 60% of children with PUV 
escaped prenatal detection. One child was diagnosed as late as 2,950 days (8 years). The 
ages at which PUV were diagnosed in this audit parallels that of a series in the British 
Isles conducted in the presonographic era in the 1970s.40 Even when all the cases of PUV 
diagnosed in the last 3 years of the audit (from January 2006 to January 2009) were 
analysed, only 6 (42.8%) out of 14 cases were identified prenatally. Considering the fact 
that this audit covers a relatively recent period, 2002 to 2009, the finding of < 40% cases 
of prenatally detected PUV highlights the generally suboptimal maternal health care 
services that often confront developing countries like Africa.  
Compared to other African countries south of the Sahara, South Africa has a strong 
economy with probably the best healthcare services. The Western Cape province, and 
Cape Town Metropolis in particular where RXCH is situated, has one of the best 
healthcare services in South Africa, and so by extension the whole of Africa. If only 
35.41% of PUVs were detected prenatally in this study in this province/metropolis, then 
the situation could be worse for less endowed provinces and probable the rest of Sub-











services in Africa, particularly in terms of universal access to prenatal ultrasound scan. 
Such an intervention could improve significantly, the number of congenital obstructive 
uropathies like PUV that are detected and treated early. The intervention will lead to 
improvement in the quality of life of the affected child. Also, some economic gains could 
be made to the state in terms of resources saved in averting the high cost of treatment for 
ESRF.    
 
5.1 Methods of clinical presentation 
Outside prenatal detection of PUV, the methods of presentation of PUV identified in this 
audit is consistent with reports in the literature.1,2,19,40 A palpable abdominal mass 
(bladder or kidney) has been described as a common finding in patients with PUV39.  In 
this audit, 4 (8.33%) patients presented that way and stress the importance of the routine 
examination of newborns. In this way it may be possible to make diagnosis before UTI 
occurs and thus lessen the severity and possibly the deterioration of renal function. 
Daytime wetting and nocturnal enuresis as presentations of PUV in older boys as 
identified in this audit have been reported by Bomalaski et al37 as the leading methods of  
late presentation of PUV and  stresses the need for thorough investigation of this social 
disorder.  
Obtaining a history of dribbling of urine in a boy is undoubtedly one of the most 
important clues to the diagnosis of PUV. There is therefore a false conception among 
doctors that a good urine stream excludes PUV. In this audit, only 2 (4.17%) of the 48 
study patients presented with dribbling of urine. In analysing 108 children with PUVs 
from 7 surgical centers in the British Isles, Atwell found only 5.5% of the children to 
have reported poor urine stream as a primary complaint.40 Thus, this widely held belief of 
“no urine dribble in a boy, no PUV” should be discarded. Instead, any symptom referable 
to the urinary tract in a boy, including bedwetting in a boy more than 5 years of age, 















5.1.1 The need for radiological evaluation for ALL boys with UTI 
Of the 29 postnatally diagnosed PUVs in this audit, 10 (34.4%) were identified during 
evaluation for UTI. In his series, Atwell JD40 identified UTI as the most common method 
of presentation of PUV in 7 paediatric surgical centers in the British Isles, accounting for 
34.2% of all methods of presentation. Because UTI is a common presenting feature in 
boys with PUV, universal radiological investigation is recommended in all boys who 
were not screened antenatally, after their first UTI. Such a recommendation though at 
variance with the NICE guideline51 on evaluation of UTI is still relevant in the Africa 
where most children never had a prenatal ultrasound scan.  
The NICE guidelines on UTI stipulate a mandatory radiological evaluation only for 
children less than 6 months of age diagnosed with UTI. For children older than 6 months, 
there should be additional features to warrant further diagnostic imaging. 
In this audit, an eight year old with history of failure to thrive and previous UTI who was 
never evaluated radiologically presented with advanced chronic renal failure and a non-
functioning left kidney. Histology on his nephrectomised kidney showed 
hydropyonephrosis from long standing hydronephrosis and pyelonephritis.  
 
5.2 Prevalence and Racial distribution of PUV 
Since RXCH receives referrals from outside the Western Cape Province, the prevalence 
of PUV in the population could not be determined in this audit. However, among the four 
racial groups in the Western Cape, PUV appears to be relatively commoner among the 
Coloured race accounting for 70.8% of all cases. This is against the background that the 
Coloured, though in the majority within the Western Cape Province, constitutes 53.9% of 
the total population of the province (Table 3.1). When the distribution of PUV among the 
Whites and Blacks who have population distribution in the Western Cape of 18.7% and 
26.7% respectively (i.e. White : Black ratio of 1 : 1.42) were compared, 13x as many 
Blacks compared to Whites were affected. This finding may give credence to the report 
by Meyers et al36 who found PUV to be more prevalent among Blacks in South Africa. 
This racial distribution of PUV may, however, be biased considering the well known fact 











insurance and are thus managed by the private sector.  Some authors have reported of no 
racial predilection of PUV.2  
 
 
5.3 Diagnostic tools in PUV 
In this audit, 3 main diagnostic tools for PUV were identified namely KUB USS, MCUG, 
and urethrocystoscopy which is in keeping with the practice elsewhere.2,43 MCUG was 
the standard tool used in confirmation of PUV as has been the practice internationally.43 
The limitation of MCUG as cautioned by Wienner JS2 was demonstrated in this audit 
when a patient with a negative MCUG film was later confirmed to have valves on 
urethrocystoscopy. Thus a proper MCUG technique must be employed at all times with 
adequate urethral views as well as removal of the urethral catheter during the voiding 
phase. Where the suspicion of PUV is strong on account of clinical and sonographic 
features, a negative MCUG should prompt urethrocystoscopic evaluation. The 
consequence of a missed diagnosis based upon false negative MCUG could be disastrous 
for the individual child and his family. The converse is also true for MCUG leading to 
false positive results. Bomalaski et al37 insists that all cases of PUVs suspected on MCUG 
must be confirmed by cystoscopy. Also in this audit, 3 cases of PUVs were diagnosed 
solely on ultrasound findings. Tejani et al demonstrated that a good sonographic 
technique could actually establish the diagnosis of PUV.43 
 
 5.4 Time interval to confirmation of diagnosis and surgical intervention 
For all obstructive uropathies including PUV, the importance of prompt diagnosis and 
subsequent definitive treatment cannot be overemphasised.1,2 In this audit, the median 
time to confirmation of diagnosis was 5 days, with more than one-third of cases (35.4%) 
being confirmed in the first 24 hours of presentation. In all, 66.6% of all cases were 
confirmed in the first 7 days of presentation.  
Median time to initial surgical intervention was equally short, 8.5 days, with the IQR 










Considering the fact that in Africa health resources, in terms of personnel and equipment, 
are often over-stretched by the low physician to patient ratio, such promptness in 
establishing diagnosis and subsequent surgical management identified in this audit is 
highly commendable. 
This commendation notwithstanding, the delay in confirmation of diagnosis as well as 
surgical intervention in some patients on account of broken down fluoroscopic machine 
and lack of appropriate endoscopic equipment (urethra too small for the available 
cystoscope) stresses the need for strengthening of the health systems in Africa. This is 
particularly important for RXCH considering its status of as a major paediatric referral 
center in South Africa and beyond. It may be argued though that equipment and 
technological failure are not unique to Africa.  
5.5 Differential diagnosis of PUV 
A case initially diagnosed as PUV was found to be idiopathic bulbar urethral stricture 
(Cobb collar) and underwent a successful urethral dilatation. This case highlights the 
importance of keeping in mind the differential diagnosis of PUV and the need for a 
pragmatic approach to investigation since the treatment for each condition is different. 
5.6 Management practices of PUV 
The management practices identified in this audit is consistent with the literature and can 
be compared to that of the developed world.1,40,52  
It has been a standard practice to place urethral catheter at the time of diagnosis to offer 
quick drainage of the system (which is often infected) while surgical intervention is being 
planned.1, 40,52,53 As Postlethwaite and Dickson put it; infection occurring within the 
closed system of posterior urethral valves can be lethal.1 In this audit, all patients had 
initial urethral catheter drainage. This is a commendable practice that can improve renal 
function and the long-term outcome of PUV. It should be embraced by all. For physicians 
operating in the peripheral institutions, this placement of urethral catheter to promote 
drainage prior to referral to higher centers should be a routine practice. 
The RXCH protocol recommends fluid replacement to manage post obstructive diuresis 











worsening of renal failure. The institution of such practice at RXCH is also 
commendable. 
Overall, many aspects of the management practices identified in this audit is standard in 
keeping with practices elsewhere in the developed world except for the deficiencies in 
follow up care.   
 
 
5.6.1 Modalities of surgical interventions 
The variety of surgical treatment of PUV described in the literature were employed in the 
management of study subjects.41,43,50 Preliminary urinary diversion has been an age old 
surgical practice particularly where the definitive treatment by valve ablation cannot be 
performed for medical and or technical reasons.1,40,50,52,54 In this audit, both lower and 
upper tract diversionary procedures, by way of vesicostomy and ureterostomies 
respectively, were employed as has been the practice elsewhere.40,41,43,52,54 It is significant 
to note that majority (60.4%) of the study patients identified in this audit  had the 
definitive surgical treatment of valve ablation as the primary and sole surgical treatment. 
This drive is consistent with the literature40,55  and is particularly important since urinary 
diversionary procedures have been reported to jeopardise the potential for bladder healing 
and normal bladder function.55,56 Puri et al55 identified in their study that primary valve 
ablation is associated with better bladder function than vesicostomy and recommended it 
to be the surgical treatment of choice. 
This audit identified surgical bladder augmentation for patients with failed medical 
treatment of bladder dysfunction, similar to what was practiced elsewhere.52 Obsolete 
valve ablation procedures like disruption of valve by blind passage of a valve hook52, 
perineal urethrostomy40, and transvesical approach to valve ablation40 were not identified 
in this audit. Instead, Bugbee electrocauterisation was the main method used which is in 
keeping with modern methods.52 
 
5.7 Urinary tract abnormalities associated with PUV 
The pathological effect of this obstructive membrane on the entire segment of the urinary 










congenital obstructive uropathy as opined by Casale.53 Unlike most upper tract 
obstruction like pelvi-ureteral junction obstruction that tends to affect one unit of the 
system, PUV commonly exerts its effect on both units of the urinary system. In this audit, 
abnormalities were identified in every segment of the tract as has been documented in 
several studies.12,50 Bladder abnormalities were detected in 75% of cases, VUR in 27.0%, 
hydroureteronephrosis in 87.4%, bifid renal pelvis 2.0%, and renal dysplasia in 12.5% of 
cases. The association of these abnormalities with PUV has well been described.12,37,50  
Two patients had myopathic bladder that were severe enough to require augmentation 
cystoplasty. This procedure has been employed elsewhere43 and confirms the diverse 
technical expertise available at RXCH. Appendicovesicostomy (Mitrofanoff principle) 
for CIC of the bladder was similarly identified in 2 cases. 
      Though bilateral hydronephrosis was the leading abnormality of the urinary tract 
identified (79.1%), it is significant to note that 8.3% of patients presented with unilateral 
hydronephrosis. Warshaw et al13 similarly identified unilateral hydronephrosis in 18.1% 
of their patients with PUV. Though bilateral hydronephrosis often with hydroureters has 
been the sonographic clue to the diagnosis of PUV, the finding of unilateral 
hydronephrosis in this study as well as elsewhere emphasise the need for any male child 
with dilatation of the urinary tract, be it unilateral or bilateral, to have MCUG study in 
order to rule out PUV. 
Six patients had renal dysplasia 2 of whom had associated unilateral vesicoureteral reflux 
with normal contralateral kidneys. This unequal distribution of the pressure effect of 
PUV among the 2 kidneys is an adaptation mechanism called vesicoureteral reflux and 
renal dysplasia (VURD) syndrome and has been described in the literature.13,36 
5.8 Associated medical conditions 
A number of medical conditions identified to be associated with PUV in this audit have 
been described in other studies.50 The association with inguinal hernia (3 cases in this 
study) is probably due to the high intraabdominal pressure that is generated during 













5.9 Complications  
5.9.1 Pop-off mechanisms 
Urinary ascites and urinomas are rare complications that may be associated with PUV. 
They result from the rupture of a calyx as a direct consequence of the high pressure build 
up in the urinary collecting system as a result of the obstructing membrane of PUV. In 
this audit, 2 each of urinary ascites and urinomas were identified. Urinary ascites, 
urinomas, together with VURD and bladder diverticula have been reported to be 
protective mechanisms (pop-off adaptive mechanisms) in PUV that serve to lower the 
intraluminal pressures and allow at least one renal unit to develop normally.2,36 
 
5.9.2 Complications from decreased foetal urine production (oligohydramnios) 
Three children had pulmonary hypoplasia and one had Potter’s sequence. Potter’s 
sequence and pulmonary hypoplasia are recognised complications that occur in PUV and 
result from oligohydramnios secondary to decreased foetal urine output.52,57 An 
appropriate volume of amniotic fluid largely produced by foetal kidney is necessary for 
complete and proper branching of the bronchial tree and alveoli.52 Modern neonatal 
intensive care units have led to dramatic reduction in neonatal mortality from obstructive 
uropathy.50 But in their study, Nakayama et al57 were of the opinion that survival from 
pulmonary hypoplasia depends on the severity of the PUV obstruction which may lead to 
irreversible pulmonary hypoplasia with fatal outcomes. They emphasised what they 
called hidden mortality of PUV on the basis that babies with severe PUV may die soon 
after birth from irreversible, fatal pulmonary hypoplasia without the underlying PUV 
being recognised. Thus, the true case fatality of PUVs may not be represented in the 
literature. In this audit, all 3 cases of PUV with pulmonary hypoplasia survived the 
neonatal period. Whether the survival is due to improvement in neonatal intensive care 
management or milder PUV cannot be determined. Again since RXCH does not have a 










cases of PUVs who did not survive the neonatal period cannot be determined in this 
audit.   
5.9.3 Other complications 
The other complications identified in this audit namely non-functioning kidney, 
pyonephrosis, hypertension, perinephric abscess have all been described elsewhere.40,41,50 
An iatrogenic complication occurred in one patient when the bladder was ruptured during 
performance of the MCUG. Care should be taken during bladder catheterization in 
patients with PUV, because of the associated bladder pathology. Histology of 3 
nephrectomised kidneys for non-functioning (2 cases) and severe pyonephrosis (1 case) 
showed end stage renal failure with hydropyonephrosis in one specimen from long 
standing hydronephrosis and pyelonephritis obviously from a missed diagnosis of the 
PUV whilst the other 2 showed renal dysgenesis with interstitial nephritis. The finding of 
non-functioning kidney in PUV even after surgical decompression of the system is not 
uncommon and has been described elsewhere.40,58 Treatment of the non-functioning 
kidneys with nephrectomy is in keeping with standard practice and is aimed at reducing 
the risk of further infection in an already damaged urinary tract.13,40 Other studies have 
equally demonstrated renal dysgenesis (dysplasia) and interstitial nephritis in such 
damaged, non-functioning kidneys.40,41 Obstructive uropathy has been shown in animal 
studies to lead to loss of nephrons25,26 and the release of fibrogenic cytokines such as TGF 
– β which leads to tubular atrophy and interstitial fibrosis.28,29,30
5.10 Progression of CKD 
The progression of CKD associated with PUV was determined based on the K/DOQI 
staging of CKD at the last follow up. At the end of the follow up period ranging from 1 
month to 216 months (median 52 months), 20 (54.1%) out of the 37 patients whose CKD 
stage could be determined were in stage 1 and therefore not in chronic renal failure. 
Sixteen (43.2%) patients had chronic renal failure, stage 2 – 4.  
Only one (2.7%) patient had ESRF (i.e. stage 5) and needed RRT. Thus, altogether, 36 










follow up of 52 months and did not require RRT. This slow progression of CKD towards 
ESRF identified in this audit could be attributed to a number of factors: 
• Firstly, a population-based registry in Italy9 and the NAPRTCS8 data have both
demonstrated that patients with congenital anomalies generally have slower
progression of early CKD towards ESRF compared to patients with glomerular
disease as has been demonstrated in this study. Other studies have similarly
demonstrated that the evolution of renal failure in children with obstructive
uropathy may be extremely prolonged.41 The duration of follow up in this audit
(median 52 months) was not long enough to witness sizable proportion of the
study subjects to be in ESRF.
• Secondly, the prompt diagnosis and therapeutic intervention employed in the
management of cases in this audit could substantially delay progression to ESRF.
The 5 days median time duration to confirmation of diagnosis by MCUG, the
35.4% confirmation within the 1st 24 hours, the median time interval to surgery of
8.5 days, the comprehensive initial medical management identified in this study,
and the collaborative team approach to management between nephrology, urology
and radiology could all contribute to the slowing of disease progression towards
ESRF.
5.10.1 Time interval to ESRF 
The time interval to the development of ESRF in this audit was 5 years 3 months.  
It appears though that the progression to ESRF is quite variable and may be related to 
multiple factors including the time when intrauterine tract obstruction developed, the 
severity of obstruction, associated renal dysplasia, and timing and type of treatment 
instituted. Tejani et al found varying time interval from 6 months to 14 year to ESRF. 
They therefore suggested prolonged follow up care for children with PUV since ESRF 
can occur many years later.43  
 5.11 Prognostic factors 
Factors that have been cited to portend poorer long-term outcome in PUV include: 










• nadir serum creatinine (post surgery) in the first year of life,13
• serum creatinine at age 1 year59
• presence of VUR,37
• age at surgery.22
In this audit, 3 factors were identified to have prognostic value of significance namely; 
• nadir serum creatinine in the first year of life following surgical relief of the
obstruction (Spearman’s rho 0.5183204, p-value 0.003),
• serum creatinine at age 1 year (Spearman’s rho 0.6815544, p-value 0.002),
• serum creatinine at diagnosis (Spearman’s rho 0.4563161, p-value 0.008).
 Nadir serum creatinine within the first year as well as creatinine level at age 1 year as 
prognostic indices have been confirmed in this study. Both may reflect the functional 
reserve of the kidney following the relief of the obstruction and hence their prognostic 
value.  
      Though age at presentation has been cited to have prognostic significant with those 
presenting early representing severe disease that often show little improvement in renal 
function after surgery,45 this could not be confirmed in this study. A previous study 
similarly failed to show any association of age at presentation with renal outcome.37 
Instead, Tejani et al43 and El-Sherbiny et al60found worse outcomes in children in whom 
diagnosis was made beyond 2 years and 1 year of age respectively. 
      Surgical intervention prior to age 1 year as a factor conferring good prognosis as put 
up by Mayor et al22 was not confirmed in a study by Warshaw et al41 when they 
demonstrated that some patients will ultimately progress to ESRF despite surgical 
intervention during the first year of life. In this study also, age at surgery as prognostic 
index could not be confirmed so were presence of VUR, bladder pathology, time interval 
taken to achieve nadir creatinine. 
      Serum creatinine at diagnosis as a prognostic factor identified in this study has also 
been reported elsewhere61 though other studies have not confirmed that.13  
Thus several prognostic factors in PUV seem to vary among different studies. It seems 
though that the most consistent factor of prognostic significance from the literature are 











5.12 Adherence to departmental protocol 
Though a comprehensive departmental protocol for PUV management is in place 
(Appendix 2), this audit identified several weaknesses in its implementation. For 
example, height measurement could not be done for 9 (25%) of the 48 patients at the last 
follow up. While it is generally accepted that height measurements could be problematic 
in children especially young infants, the importance of such measurements in assessing 
nutritional status and growth of such children with chronic kidney disease cannot be 
over-emphasised. Height measurements are also vital input in estimating GFR for 
classification of CKD as well as appropriate interpretation of blood pressure. Efforts 
should therefore be made to strengthen anthropometric measurements at both the 
nephrology and urology clinics.  
      Another reason that might have accounted for this low adherence to the PUV protocol 
may be the non-availability of the protocol at the clinics. Most clinicians may not be 
aware of the protocol details off hand.  
5.13 Outcome of study patients 
5.13.1 Stage of CKD 
Over the duration of follow up, 36 (97.3%) out of the 37 patients whose eGFR could be 
determined were in early stages of CKD (i.e. stage 1-4). Only one (2.7%) patient was in 
ESRF (i.e. stage 5) and needed RRT. 
5.13.2 Renal replacement therapy 
The sole patient who needed RRT reached ESRF over a follow up period of 5 years 3 
months. RRT in the form of peritoneal dialysis was instituted at age 5 years 4 months and 
was successfully transplanted 5 months later. At 10 years of age during the last follow up, 










5.13.3 Survival outcome 
Over the duration of follow up, no mortality has been recorded officially. It is significant 
to note, however, that 14 (29.1%) cases have been lost to follow up for more than a year 
and therefore survival outcomes could not be accurately determined. Migration out of 











SUMMARY AND CONCLUSION 
6.0 Summary 
Posterior urethral valves are common causes of chronic kidney disease in boys.  
Close to 40% of children with PUV (35.41%) were prenatally detected based on 
hydronephrosis (4 unilateral). Though this number could be said to be sub-optimal means 
of diagnosis of PUV in the light of the near 100% prenatal detection in most developed 
world, for a developing continent like Africa it offers hope that with little effort at 
improving antenatal care services in terms of universal access to prenatal ultrasound, 
more cases of PUVs and other renal congenital abnormalities could de diagnosed 
prenatally.  
      For those cases of PUVs that escaped prenatal detection, 75.8% were diagnosed 
within 1 year of age with variable presentations. Clinical presentations identified in this 
audit were similar to reports from the literature. The common presentations were urinary 
tract infection (10 cases), palpable abdominal mass (4 cases), voiding difficulties (3 
cases) and enuresis (2 cases). Dribbling of urine at micturition in boys which has long 
been considered to be an important finding PUV was found in only 2 (4.17%) of the 48 
study patients and was consistent with the 5.5% of cases in another study.40 Thus, this 
widely held belief of “no urine dribble in a boy, no PUV” should probably be discarded. 
Instead, any symptom related to the urinary tract in a boy, including daytime wetting or 
enuresis after the age of 5, warrants some investigation to rule out PUV.  
      Ten (34.4%) of the 29 postnatally diagnosed PUVs in this study were identified 
during evaluation for UTI with some more than 5 years of age at presentation (1 case was 
8 years old). Thus the NICE guideline on UTI evaluation may not be relevant in the 
African setting where most children never had a prenatal ultrasound scan. 
Though many more Blacks (13x) compared to Whites had PUV in this study (black:white 










considering the well known fact that in South Africa, more White patients than Blacks 
and Coloured have private medical insurance and are thus managed in the private sector.   
      Ultrasonography was a useful tool in PUV screening in this study though micturiting 
cystourethrogram was the main radiological tool used in confirmation of PUVs. There 
was 1 case with false negative MCUG findings that was confirmed on urethrocystoscopy 
and highlights the limitation of this radiological method.  
      The time interval from suspicion of diagnosis to confirmation was swift with 
seventeen (35.4%) out of the 48 cases being confirmed within the first 24 hours. Overall, 
the median time to confirmation of diagnosis was 5 days with 66.6% of cases being 
confirmed in the first 7 days of presentation.  
Median time to initial surgical intervention was equally short, 8.5 days, with the IQR 
being 6 - 15days. Various surgical techniques in the management of PUVs which were in 
keeping with management practices in the developed world were identified in this study.  
      Most cases of PUV identified in this study (97.3%) were in earlier stages (stage 1-4) 
of CKD at the end of duration of follow up which ranged from 1 month to 216 months 
(median 52 months). Only 1 patient had reached ESRF over a time interval of 5 years 3 
months. He has since been transplanted successfully with preserved graft function at 4 
years months. No death had been registered during the period of this study but significant 
number (29%) have been lost to follow up for over a year.  
The prognostic indicators identified in this study population were similar to other reports 
in the literature. There was a coordinated team approach to the management of PUV at 
RXCH involving the departments of radiology, urology and nephrology. 
Though significant successes were identified in this study in terms of promptness of 
diagnosis and surgical intervention, several areas in follow up care need improvement. 
6.1 Conclusions 
      In conclusion, the experience of PUV management at RXCH, Cape Town, gives hope 
to Africa and the rest of the developing world and highlights the point that with the right 
priorities given to the health sector by African governments, coupled with a well 
determined and motivated team of health professionals, congenital kidney anomalies like 











ESRF. Such an approach will not only improve the quality of life of the African child 
with chronic kidney disease, but could save our national budgets substantial amount of 
money in averting the expensive treatment cost of ESRF.  
 
6.2 Recommendations 
• With the emerging prenatal ultrasound scan as a routine tool in maternal 
healthcare services in most part of Africa, there is the need to create the 
awareness of screening for foetal abnormalities like hydronephrosis among 
obstetricians and sonographers so that obstructive uropathies like PUVs could be 
detected prenatally in keeping with modern trends. 
• The departmental protocol on PUV needs to be strictly adhered to. The joint 
nephrology-urology clinical meetings could be used to discuss the protocol to 
create much awareness of it. Copies of the protocol should be incorporated into 
the folders of all cases of PUV for easy reference and to promote adherence to its 
contents among clinicians. 
• For every male child who is diagnosed with urinary tract infection irrespective of 
age, or has daytime incontinence after 5 years, a palpable bladder and/or kidney, 
PUV should be ruled out through appropriate imaging studies. 
• There is the need for up-gradement of the logistics, particularly surgical 
equipments like cystoscope, to enhance service delivery. 
 
6.3 Limitations of study 
• Because this was a retrospective folder review, folders that could not be traced at 
the time of the audit could not be included and may thus affect the true 
representation of PUV over the study period. 
• The study population may not be true representative of the population of the 
Western Cape for two reasons:  
i) there is no “onsite” neonatal unit at RXCH. Thus, cases of PUVs with 
severe respiratory distress from pulmonary hypoplasia either died or 










ii) more White patients with private medical insurance might have been
managed at the private sector. This is an established practice in South
Africa.
• The short duration of follow up in this audit (median 52 months) may not have
allowed for the accurate evaluation of treatment outcomes (time to reach ESRF)
in the study patients.
6.4 Need for further studies 
There is the need to replicate this study in other provinces in South Africa or other 
African countries considered less endowed than Cape Town to get the true picture of the 
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PATHOLOGICAL SPECIMEN SHOWING PUV 
Pathological specimen showing posterior urethral valve. The urethra is obstructed and the 
bladder wall is markedly thickened. (Source: Paediatric nephrology and urology; the 

























CASE REPORT FORM 
 
Folder no. …………DOB………Age diagnosis suspected/confirmed……/………. 
 
Height at 1-year & at last follow up (cm)……/…..Race: white [   ] black [   ] coloured [  
] 
 
Presenting symptoms (tick) 
 
Prenatal HN  [  ]    UTI [   ]   Kidney mass [   ]   Weak urine stream [   ]  FTT [   ] 
 
Urinary incontinence [   ]      Renal failure [   ]    Others (state) …………..    
 
Urinary tract abnormalities associated with PUVs (tick):  
 
 HN [   ]  VUR [   ]    Renal dysplasia [   ] Thickened bladder [   ]  
 
 Bladder diverticulum’s [   ]    Others state)…………………………..                              
 
Complications associated with PUVs (state)…………………….. 
 
Co-morbid conditions (state): ………………………….. 
 
Age at initial surgical intervention (months): ………….    
 
Type of surgery: Vesicostomy [   ]   Valve ablation [   ]  Ureterostomy [   ] Others 
 
Serum creatinine at: 
 Diagnosis (pre-surgery)…………Nadir value post-surgery………… 
 
1-year of age……………                   Last follow up………….. 
 
Patient’s outcome at last follow up (tick): 
 
Outcome 1: eGFR…….ml/min/1.73m2          Stage of CKD……………….. 
 
 Outcme 2:            On RRT?      Yes [   ]                    No [   ] 
 
                    If yes, state type……………………Time to ESRF………. 
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